COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, July 20, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
76 new cases, bringing the total number of people infected to 376,416*;
364,540 people have recovered;
0 new deaths, for a total of 11,236 deaths;
77 hospitalizations, for a decrease of 1;
21 people in intensive care, for a decrease of 2;
9,754 samples conducted on July 18.
*Due to an update of reported cases, mostly in the Montréal area, 91 cases were removed from the total case history. This change caused a variation in the total number of people infected as well as the total number of people who have recovered.
Vaccination
83,673 doses administered are added, that is 82,153 doses in the last 24 hours and 1,520 doses before July 19, for a total of 10,167,756 doses administered in Québec. Outside Québec, a total of 32,201 doses were administered, for a cumulative total of 10,199,957 doses received by Quebecers.
627,120 of the 703,170 doses of Pfizer expected this week were received yesterday.
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...